KOLON LIFE SCIENCE Inc. Logo

KOLON LIFE SCIENCE Inc.

Develops gene therapies and manufactures APIs, providing global CDMO/CMO services.

102940 | KO

Overview

Corporate Details

ISIN(s):
KR7102940004
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡동로 110 코오롱 One&Only 타워, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kolon Life Science Inc. is a biopharmaceutical and chemical company with two core business segments. The Bio division focuses on the research and development of innovative cell and gene therapies, targeting areas such as neuropathic pain and oncolytic virus treatments for cancer. The Chemical division manufactures and supplies high-quality Active Pharmaceutical Ingredients (APIs) and specialty chemicals. Leveraging its technical expertise, the company also provides Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) services for global pharmaceutical partners, adhering to cGMP standards.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-11 00:00
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
Korean 14.6 KB
2025-09-09 00:00
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
Korean 14.5 KB
2025-09-04 00:00
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
Korean 14.5 KB
2025-08-28 00:00
Related Party Transaction
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 8.5 KB
2025-08-27 00:00
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
Korean 13.8 KB
2025-08-14 00:00
Regulatory News Service
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 11.1 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.7 MB
2025-08-13 00:00
Legal Proceedings Report
[기재정정]재해발생
Korean 12.4 KB
2025-07-24 00:00
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
Korean 16.6 KB
2025-07-22 00:00
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
Korean 16.6 KB
2025-07-14 00:00
M&A Activity
[기재정정]투자판단관련주요경영사항 (TGC 기술이전 계약 체결)
Korean 20.5 KB
2025-07-10 00:00
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
Korean 16.1 KB
2025-07-09 00:00
Legal Proceedings Report
소송등의제기ㆍ신청(일정금액이상의청구)
Korean 8.0 KB
2025-07-08 00:00
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
Korean 15.6 KB
2025-06-30 00:00
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
Korean 15.2 KB

Automate Your Workflow. Get a real-time feed of all KOLON LIFE SCIENCE Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOLON LIFE SCIENCE Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOLON LIFE SCIENCE Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Develops cord blood stem cell therapies for osteoarthritis & infant lung disease, plus banking.
South Korea
078160
MediWound Ltd. Logo
Develops enzymatic therapies for non-surgical tissue repair in burns and chronic wounds.
United States of America
MDWD
Medizen Humancare Inc Co., Ltd Logo
Offers DTC genetic testing and genomic analysis for personalized disease risk prediction.
South Korea
236340
Medy-Tox Inc. Logo
Develops and markets botulinum toxins and dermal fillers for global aesthetic & therapeutic use.
South Korea
086900
MeiraGTx Holdings plc Logo
Develops genetic medicines for eye, salivary gland, and CNS disorders using gene regulation tech.
United States of America
MGTX
Meito  Sangyo  Co., Ltd. Logo
Produces food products and specialty chemicals for industrial and pharmaceutical applications.
Japan
2207
Merck & Co., Inc. Logo
A global biopharma developing innovative medicines, vaccines, and animal health products.
United States of America
MRK
Mereo BioPharma Group plc Logo
A clinical-stage biopharma developing and commercializing novel therapies for rare diseases.
United States of America
MREO
Mersana Therapeutics, Inc. Logo
Developing innovative antibody-drug conjugates using proprietary platforms to treat cancer.
United States of America
MRSN
Merus N.V. Logo
Develops multispecific antibody therapies that harness the immune system to fight cancer.
United States of America
MRUS

Talk to a Data Expert

Have a question? We'll get back to you promptly.